PRVA (NASDAQ: PRVA) Form 144 for 6,453 Shares from Vesting

Rhea-AI Filing Summary

PRVA filed a Form 144 to sell 6,453 shares of Common Stock. The filing lists the proposed sale as resulting from restricted stock vesting tied to compensation with a transaction date of 03/11/2026 and names Fidelity Brokerage Services LLC as the broker. The filing also lists multiple sales by David Mountcastle during the prior three months: 23,887 shares on 12/12/2025, 5,361 shares on 02/26/2026, 7,697 shares on 02/27/2026, 5,177 shares on 03/06/2026, and 5,829 shares on 03/09/2026, with dollar proceeds listed alongside each sale.

Insights

Securities Counsel

Form 144 notifies the market of an affiliate's planned sale after a restricted stock vesting event.

Form 144 serves as a compliance notice for sales by persons deemed affiliates under Rule 144. The filing here links the proposed sale of 6,453 shares to restricted stock vesting on 03/11/2026 and identifies Fidelity Brokerage Services LLC as the executing broker.

Past transactions by David Mountcastle are listed with specific dates and share counts; these are dispositions that occurred within the three‑month lookback. Cash‑flow treatment and any sale timing beyond the 03/11/2026 date are not specified in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6453	141317.47	123688289	03/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Restricted Stock Vesting	Issuer			6453	03/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	12/12/2025	23887	597793.14
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Comomn	02/26/2026	5361	134030.87
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/27/2026	7697	192798.08
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/06/2026	5177	119852.73
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/09/2026	5829	133158.26

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PRVA's Form 144 filing report?

The filing reports a proposed sale of 6,453 shares of Common Stock tied to restricted stock vesting dated 03/11/2026, with Fidelity Brokerage Services LLC named as broker.

Who is listed as the broker for the PRVA sale?

The filing names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker associated with the proposed sale of 6,453 shares.

Were there other recent insider sales disclosed for PRVA?

Yes; the filing lists sales by David Mountcastle: 23,887 shares on 12/12/2025, 5,361 on 02/26/2026, 7,697 on 02/27/2026, 5,177 on 03/06/2026, and 5,829 on 03/09/2026 with proceeds shown for each sale.

Does the Form 144 state how proceeds will be used?

The excerpt ties the shares to compensation-related restricted stock vesting; it does not state any use of sale proceeds or who will receive them beyond the selling holder information.

Is the proposed sale immediate under the Form 144?

The filing shows a transaction date of 03/11/2026 for the vested restricted shares; additional timing or settlement details for execution are not provided in the excerpt.